May 2, 2017 08:57 AM EDT
Discovery
Pharma

Lit­tle Abi­vax sees volatile shares rock­et up on a (very ear­ly-stage) re­port of an HIV break­through

Arsalan Arif

Founder

Abi­vax is wit­ness­ing the lat­est gy­ra­tion in its stock price af­ter claim­ing it’s gath­ered ev­i­dence of suc­cess in elim­i­nat­ing a sig­nif­i­cant amount of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times